US Pre-Market SEC Filings Roundup — January 07, 2026

08-01-2026

Curis Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001108205-26-000002, Size: 1 MB), reporting events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no transaction values, share counts, financial metrics, named parties, or other quantitative details disclosed in the provided information.

08-01-2026

T-REX Acquisition Corp. filed an 8-K on 2026-01-08 (AccNo: 0001477932-26-000088, Size: 136 KB) disclosing a Merger/Acquisition under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.

08-01-2026

Terreno Realty Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006930), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the transaction, parties, dollar values, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

08-01-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002315, Size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.

08-01-2026

Enpro Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000570, Size: 139 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or quantitative data are provided in the summary. Sector is not specified.

08-01-2026

The company filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001896, Size: 193 KB) under Item 8.01 Other Events, classified as a General Filing. No specific event details, transaction values, financial metrics, or named entities are disclosed in the provided filing information. Sector is not specified.

08-01-2026

ACRO BIOMEDICAL CO., LTD. filed a Form 8-K on January 08, 2026, reporting changes in its certifying accountant under Item 4.01 and including financial statements and exhibits under Item 9.01. No specific details on the accountant change, financial metrics, transaction values, or other numerical data are disclosed in the filing summary. This is a multi-item mandatory disclosure with file size of 138 KB and AccNo 0001640334-26-000053.

08-01-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006699, Size: 146 KB) reporting under Item 7.01 Regulation FD Disclosure. No details on the content of the disclosure, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.

08-01-2026

Crown Electrokinetics Corp. filed an 8-K on 2026-01-08 (AccNo: 0001213900-26-002308, Size: 231 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement and Item 2.01 Completion of Acquisition or Disposition of Assets. Item 9.01 provides Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, consideration, or financial metrics are disclosed.

08-01-2026

Compass, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001563190-26-000009, Size: 190 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC with sector not specified.

08-01-2026

Neuphoria Therapeutics Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002245, size 293 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a material definitive agreement, with financial statements and exhibits under Item 9.01. No details on the agreements, parties, values, or impacts are disclosed. This is a multi-item mandatory filing as a material event.

08-01-2026

Catheter Precision, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000839, Size: 287 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or other terms are disclosed.

08-01-2026

Kinsale Capital Group, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001669162-26-000004, Size: 4 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other numerical data are explicitly stated. Sector is not specified.

08-01-2026

NEWS CORP filed a Form 8-K on January 08, 2026 (AccNo: 0001564708-26-000005, Size: 400 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other event, financial statements, exhibits, transaction values, or other quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Brookfield Asset Management Ltd. filed a Form 8-K on January 08, 2026 (AccNo: 0001171843-26-000130, Size: 216 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.

08-01-2026

Global Net Lease, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001919, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided. Sector not specified.

08-01-2026

Helen of Troy Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0000916789-26-000007, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or detailed results are disclosed in the provided filing summary. This is a multi-item filing focused on earnings-related disclosures.

08-01-2026

Vanda Pharmaceuticals Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001273, Size: 238 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

08-01-2026

RPM International Inc./DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006976, Size: 472 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.

08-01-2026

Climb Bio, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006994, Size: 203 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content from the filing is disclosed in the provided summary. All quantitative data and impacts are NOT_DISCLOSED.

08-01-2026

TELEFLEX INC filed a Form 8-K on January 08, 2026 (AccNo: 0000096943-26-000003, Size: 192 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also covers Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, reason, financial metrics, or quantitative data are provided.

08-01-2026

Jasper Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002329, Size: 36 MB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

08-01-2026

Amylyx Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006991, Size: 20 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary. All quantitative financial data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

08-01-2026

Xeris Biopharma Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001867096-26-000004, Size: 222 KB) reporting under Item 2.02 for Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of financial results.

08-01-2026

TD SYNNEX CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001271, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This appears to be a voluntary disclosure of financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

08-01-2026

V F CORP filed a Form 8-K on January 08, 2026 (AccNo: 0000103379-26-000004, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, or exhibits are provided. Sector not specified.

08-01-2026

Indivior PLC filed a General Filing (likely Form 8-K) on January 08, 2026 (AccNo: 0001193125-26-006993), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction, or financial impacts provided in the filing summary. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.

08-01-2026

Opus Genetics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000615, Size: 188 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. All specific numbers such as transaction values, share counts, or percentages are NOT_DISCLOSED.

08-01-2026

Soho House & Co Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001140361-26-000611, Size: 170 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other material information are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Amarin Corp PLC/UK filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006992, Size: 333 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market. No quantitative financial metrics, transaction values, or specific details are disclosed in the provided filing summary.

08-01-2026

NEOGEN CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006990, Size: 904 KB) reporting financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US SEC. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

Cullinan Therapeutics, Inc. filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-006998, Size: 225 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary financial results disclosure with no specific financial metrics, transaction details, or quantitative data disclosed in the provided summary.

08-01-2026

Simply Good Foods Co filed a Form 8-K on January 8, 2026 (AccNo: 0001702744-26-000004, size 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, transaction values, guidance, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.

08-01-2026

Invivyd, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006997), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific financial metrics, transaction details, or numerical values disclosed in the provided summary. Sector is not specified.

08-01-2026

STANDARD BIOTOOLS INC. filed an 8-K on January 08, 2026 (AccNo: 0001193125-26-006996, Size: 294 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Lindsay Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007004, size 10 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market, sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

08-01-2026

Entrada Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001689375-26-000003, Size: 212 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item filing related to financial results in the US market. No specific financial metrics, transaction details, or numerical values are disclosed in the provided filing summary.

08-01-2026

Acuity Inc. (DE) filed a Form 8-K on January 8, 2026 (AccNo: 0001144215-26-000012, Size: 441 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a standard earnings-related 8-K. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

08-01-2026

Context Therapeutics Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001275, Size: 5 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other quantitative data are specified in the filing summary. Sector is not specified.

08-01-2026

AMERICAN ELECTRIC POWER CO INC filed a Form 8-K on January 08, 2026, reporting under Item 8.01 Other Events. Accession Number: 0000004904-26-000003. File size: 184 KB; no specific details on the event or transaction disclosed.

08-01-2026

Acrivon Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007007, Size: 331 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

Soluna Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000891, Size: 333 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, transactions, financial metrics, or named entities beyond the filer are provided. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.

08-01-2026

Bone Biologics Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000896, Size: 287 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure with no specified timing relative to events.

08-01-2026

Xencor Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001326732-26-000002, Size: 191 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Collegium Pharmaceutical, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001953, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

Century Therapeutics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001952, Size: 7 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. Sector is not specified.

08-01-2026

MEXICO FUND INC filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000168, Size: 199 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are specified in the filing summary. This appears to be a multi-item voluntary filing focused on regulatory compliance and exhibits.

08-01-2026

Spruce Biosciences, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007038, Size: 1 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector not specified.

08-01-2026

Personalis, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007037, size 235 KB), reporting results of operations and financial condition under Item 2.02. The filing also includes financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided summary.

08-01-2026

Limitless X Holdings Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000895), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction values, share counts, dollar amounts, or named entities beyond the filer disclosed. Sector is not specified.

08-01-2026

Beneficient filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000893, Size: 10 MB) as a multi-item disclosure covering Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, share counts, or other quantitative metrics are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing related to equity transactions and corporate governance changes.

08-01-2026

Axil Brands, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001520138-26-000007, Size: 319 KB) disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, revenue, earnings, or other quantitative data are provided in the filing summary. This is a multi-item filing focused on financial results with no additional named entities or key facts extracted.

08-01-2026

GRI Bio, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001824293-26-000002, Size: 250 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector not specified. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

08-01-2026

MoonLake Immunotherapeutics filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002344, Size: 250 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Frontier Group Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007030, Size: 170 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or share counts are mentioned.

08-01-2026

Voyager Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001104659-26-001955, Size: 8 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

08-01-2026

Walmart Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000104169-26-000008, Size: 258 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Sector is not specified.

08-01-2026

CorMedix Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002350, Size: 297 KB), reporting an Officer Change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position, reason for change, or financial metrics are disclosed in the provided filing summary. Sector not specified.

08-01-2026

Murphy Oil Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000950103-26-000244, Size: 530 KB), reporting under Items 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific event details, transaction values, or financial metrics provided in the summary. Sector not specified.

08-01-2026

Northern Technologies International Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001171843-26-000135, Size: 338 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.

08-01-2026

Ardelyx, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437402-26-000003, Size: 152 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, revenue, earnings, or quantitative impacts are disclosed in the provided filing summary. This appears to be a standard financial results disclosure from the US SEC.

08-01-2026

Lightwave Logic, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001079973-26-000061, Size: 194 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed in the provided summary. Sector is not specified.

08-01-2026

Leslie's, Inc. disclosed an Item 5.02 event in an 8-K filing on January 8, 2026 (AccNo: 0001193125-26-007067, Size: 183 KB), related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

NewtekOne, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001282, Size: 8 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.

08-01-2026

Alaunos Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007054, Size: 580 KB), reporting under Item 1.02 termination of a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the events, transaction values, or financial impacts are provided in the summary. Sector is not specified.

08-01-2026

Commercial Metals Co filed an 8-K on January 8, 2026 (AccNo: 0000022444-26-000009, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.

08-01-2026

SELLAS Life Sciences Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001957, Size: 192 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results and other events from the US SEC. No specific financial metrics, transaction values, or numerical data are disclosed in the provided filing summary.

08-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007042, Size: 144 KB), reporting under Item 8.01 Other Events. No details on the specific event, transaction, financial impact, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Xilio Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007063, size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). Event dated January 08, 2026; sector not specified. No specific details on officer position, appointment/resignation, reasons, or financial metrics provided.